FVIII dosages in persons with haemophilia A treated with extended half-life products: From local biology to optimized patient management.

Subjects

Subjects :

Adolescent
Adult
Aged
Child
Child, Preschool
Coagulants administration & dosage
Coagulants pharmacokinetics
Disease Management
Drug Monitoring
Factor VIII administration & dosage
Factor VIII pharmacokinetics
Half-Life
Humans
Middle Aged
Recombinant Proteins administration & dosage
Recombinant Proteins pharmacokinetics
Recombinant Proteins therapeutic use
Young Adult
Coagulants therapeutic use
Factor VIII therapeutic use
Hemophilia A drug therapy

Details

Language :

English

ISSN :

1365-2516

Volume :

25

Issue :

6

Database :

MEDLINE

Journal :

Haemophilia : the official journal of the World Federation of Hemophilia

Publication Type :

Editorial & Opinion

Accession number :

31206947

Full Text :

https://doi.org/10.1111/hae.13801